HC ADVISORS, LLC – Apellis Pharmaceuticals, Inc. Transaction History
HC ADVISORS, LLC portfolio value:
$2.82M
portfolio value
HC ADVISORS, LLC quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +476.19% | 34.18K shares | 2.5M | $68.3 | 41.36K |
| Q2 2022 | share | Increase | +4.36% | 300 shares | -25K | $45.22 | 7.17K |
| Q1 2022 | share | Decrease | -42.96% | -5.18K shares | -220K | $50.81 | 6.87K |
| Q4 2021 | share | Increase | 0.00% | 12.06K shares | 570K | $47.95 | 12.06K |
| Q3 2021 | share | Decrease | -100.00% | -3.31K shares | -209K | $32.96 | 0 |
| Q2 2021 | share | Decrease | -40.07% | -2.21K shares | -28K | $63.2 | 3.31K |
| Q1 2021 | share | Decrease | -3.41% | -195 shares | -90K | $42.91 | 5.52K |
| Q4 2020 | share | Increase | 0.00% | 5.71K shares | 327K | $57.2 | 5.71K |